Dyadic International, Inc.
NASDAQ:DYAIBiotechnology
+$0.26 today
- Market cap
- $53.56M
- Beta
- 1.15
- P/E (TTM)
- -6.9
- EPS (TTM)
- -$0.20
Volume 0.71M
Average 0.31M
DYAI Gross Margin
Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.
Dyadic International, Inc.NASDAQ: DYAI
Gross Margin · Q1 FY2026 · quarter ended Mar 2026
Gross margin widens to 28.7%
Gross margin was 28.7% in Q1 FY2026, up 91.3 pp from a year earlier. On a trailing-twelve-month basis it was 31.3%, down 28.4 pp year over year. Over 3 fiscal years it narrowed by 115.8 pp.
Context
- Gross margin widened in 2 of the last 3 fiscal years.
- FY2025 was the lowest level in the 4 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -88.3%
- Year-over-year change
- -154.1pp
| Period | Period end | Gross Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -88.3% | -154.1pp |
| FY2024 | 2024-12-31 | 65.8% | +34.0pp |
| FY2023 | 2023-12-31 | 31.8% | +4.3pp |
| FY2022 | 2022-12-31 | 27.5% | +8.4pp |
| FY2021 | 2021-12-31 | 19.1% | — |
Gross Margin vs competitors
How DYAI compares with its peers on the latest reported figures
- DYAI's LTM Mar 2026 gross margin of 31.3% is the lowest of the 4 companies compared; the peer median is 78.7%.
- Its year-over-year change of -28.4 pp is the lowest of 4, against a peer median of +3.7 pp.
- Over three fiscal years its change of -115.8 pp compares with a peer median of +45.1 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| FY2025 | 97.7% | +3.0 pp | +4.8 pp | |
| LTM Mar 2026 | 78.7% | +17.9 pp | — | |
| LTM Dec 2025 | 76.0% | +3.7 pp | +85.4 pp | |
| LTM Mar 2026 | 31.3% | -28.4 pp | -115.8 pp | |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| Peer median (excluding DYAI) | 78.7% | +3.7 pp | +45.1 pp | |
Competitors are the stored peer set for DYAI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.4M | 2.93M | 2.9M | 3.5M | 1.23M |
| Cost of Revenue | 1.94M | 2.12M | 1.98M | 1.19M | 2.32M |
| Gross Profit | 459.39K | 807.11K | 922.96K | 2.3M | (1.09M) |
| Gross Margin | 19.1% | 27.5% | 31.8% | 65.8% | -88.3% |
| Research & Development | 8.39M | 4.5M | 3.3M | 2.04M | 2.15M |
| Selling, General & Admin | 6.7M | 6.42M | 5.82M | 6.13M | 5.76M |
| Operating Expenses | 15.19M | 10.97M | 9.15M | 8.2M | 6.06M |
| Depreciation & Amortization | 3.49M | 0 | 38.42K | 0 | 0 |
| EBITDA | (11.14M) | (10.12M) | (8.15M) | (5.38M) | (6.91M) |
| EBITDA Margin | -463.4% | -345.2% | -281.3% | -154.0% | -560.6% |
| Operating Income | (14.73M) | (10.17M) | (8.23M) | (5.9M) | (7.15M) |
| Operating Margin | -612.7% | -346.9% | -283.9% | -168.8% | -579.9% |
| Interest Income | 51.7K | 180.42K | 416.69K | 456.99K | 284.09K |
| Interest Expense | 0 | 0 | 0 | 427.97K | 455.9K |
| Other Income / Expenses | 1.66M | 430.42K | 1.43M | 91.66K | (218.71K) |
| Income Before Tax | (13.07M) | (9.74M) | (6.8M) | (5.81M) | (7.36M) |
| Pre-Tax Margin | -543.7% | -332.2% | -234.4% | -166.2% | -597.6% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (13.07M) | (9.74M) | (6.8M) | (5.81M) | (7.36M) |
| Net Margin | -543.7% | -332.2% | -234.4% | -166.2% | -597.6% |
| EPS (Basic) | (0.47) | (0.34) | (0.24) | (0.20) | (0.23) |
| EPS (Diluted) | (0.47) | (0.34) | (0.24) | (0.20) | (0.23) |
| Weighted Avg Shares | 27.84M | 28.36M | 28.8M | 29.32M | 32.62M |
| Weighted Avg Shares (Diluted) | 27.84M | 28.36M | 28.8M | 29.32M | 32.62M |
Dyadic International, Inc.
NASDAQ:DYAI
Intrinsic Alpha fair value
Locked
Current Price
$1.47
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.